Rajko Healthcare Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 12 years 3 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.15 M
as on 04-07-2024
- Revenue 1977398.00%
FY 2020
- Profit 35488.00%
FY 2020
- Ebitda 114.24%
FY 2020
- Net Worth 12.26%
FY 2020
- Total Assets 12.89%
FY 2020
About Rajko Healthcare
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The Corporate currently has active open charges totaling ₹1.15 M.
Jitendra Kothawade and Sanjana Kothawade serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC232021
- Company No.
232021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rajko Healthcare Private Limited offer?
Rajko Healthcare Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Remdesivir Injection, Protein Powder, Chocolate Protein Powder, Antacid Drugs, Rabeprazole Domperidone Capsule, Calcium Tablet, Calcium Citrate and Vitamin D3 Tablet, Antibacterial Drugs, Cefoperazone Sulbactam Injection.
Who are the key members and board of directors at Rajko Healthcare?
Board Members(2)
Financial Performance and Corporate Structure Insights of Rajko Healthcare.
Rajko Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 1977398% increase. The company also saw a substantial improvement in profitability, with a 35488% increase in profit. The company's net worth Soared by an impressive increase of 12.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajko Healthcare?
Unlock access to Rajko Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
1 year 7 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Nov 2019 | ₹1.15 M | Open |
How Many Employees Work at Rajko Healthcare?
Unlock and access historical data on people associated with Rajko Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajko Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajko Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
